Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis

NCT02229747 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharyngitis

Interventions

DRUG: Meloxicam
DRUG: Diclofenac
DRUG: Nimesulide

Sponsor

Boehringer Ingelheim